0000899866-14-000204.txt : 20140918 0000899866-14-000204.hdr.sgml : 20140918 20140918173355 ACCESSION NUMBER: 0000899866-14-000204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140916 FILED AS OF DATE: 20140918 DATE AS OF CHANGE: 20140918 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LEONARD CENTRAL INDEX KEY: 0001231949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 141110652 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_141107602489819.xml FORM 4 X0306 4 2014-09-16 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231949 BELL LEONARD C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 CEO Common Stock, par value $.0001 per share 2014-09-16 4 M 0 32047 17.65 A 1053321 D Common Stock, par value $.0001 per share 2014-09-16 4 S 0 12878 159.87 D 1040443 D Common Stock, par value $.0001 per share 2014-09-16 4 S 0 19169 160.53 D 1021274 D Common Stock, par value $.0001 per share 2014-09-18 4 S 0 12388 161.45 D 1008886 D Option to Purchase Common Stock 17.65 2014-09-16 4 M 0 32047 0 D 2008-04-09 2018-01-09 Common Stock 32047.0 0 D This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $159.15 - $160.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $160.15 - $161.50. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. The sale of common stock reported by this Form 4 consists of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $161.45 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person. /s/ Michael Greco, Attorney-in-Fact 2014-09-18